MCM
AUXL

Manchester Capital Management’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Manchester Capital Management’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-335
Closed -$6K – 993
2013
Q3 		$6K Hold
335
– – ﹤0.01% 891
2013
Q2 		$6K Buy
+335
New +$5.35K ﹤0.01% 904

Other funds holding AUXL

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
TCP
TAMRO Capital Partners Alexandria, Virginia $369M AUM 1.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manchester Capital Management's AUXL Position: Q4 2013 in Review

Manchester Capital Management sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q4 2013, closing a stake of 335 shares — an estimated $6K sold.

Manchester Capital Management first reported a position in AUXL in Q2 2013 and held it in 2 quarters. The position peaked at $6K in Q3 2013. 147 funds tracked by Wall St. Rank hold AUXL as of Q4 2013.

  • Manchester Capital Management reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Manchester Capital Management sold 335 AUXILIUM PHARAMCEUTICALS INC shares in Q4 2013, an estimated $6K.
  • Manchester Capital Management first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Manchester Capital Management's AUXILIUM PHARAMCEUTICALS INC position peaked at $6K in Q3 2013.
  • 147 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2013.

Based on Manchester Capital Management's 13F filing for Q4 2013, filed 10 Feb 2014.